The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Thank you for the oppotuniey. Sir, with respect to this inspection at Bengaluru, while the response has been submitted, can you share the timeline
for implementation of the measures?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
AUGUST 09, 2024 / 3:30AM, BION.NS - Q1 2025 Biocon Ltd Earnings Call
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Any broad timeline you would want to share to implement this and how is the approvals of the product will be subject to the implementation of
the CAPA?
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Sure, sir. And progress on the Malaysia side, from a compliance point of view?
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Sure. Effectively that would also as a timeline, 3 months to 5 months can be considering the inspection timeline for Malaysia side?
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Sure, sir. And just lastly on the Generic Liraglutide and considering the business prospects for Biocon Generics, how do we see like -- what kind of
scale up can we expect if you could quantify, let's say, second half FY25, we expect this business to scale up. And if you could also elaborate on the
Liraglutide opportunity per se.
Question: Tushar Manudhane - Motilal Oswal Financial Services Limited - Analyst
: Just one more on this. As far as API capacity is concerned, do we have sufficient capacity to cater at least for next couple of years or would we need
further investment for Liraglutide API?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
AUGUST 09, 2024 / 3:30AM, BION.NS - Q1 2025 Biocon Ltd Earnings Call
| 
